Skip to main content
VCbacked
Log inGet Started

Tavros Therapeutics

Durham, United States

Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.

$17.5M raised
Oct 2022
Corporate Round
BiotechnologyHealth CareTherapeuticsWellness

Top Investors

Alexandria Venture InvestmentsKdT VenturesVividion TherapeuticsPiedmont Capital Investments

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tavros Therapeutics

How much funding has Tavros Therapeutics raised?
Tavros Therapeutics has raised $17.5M in total funding. The most recent round was Corporate Round. The last funding was announced in October 2022.
Who are Tavros Therapeutics's investors?
Tavros Therapeutics's investors include Alexandria Venture Investments, KdT Ventures, Vividion Therapeutics, Piedmont Capital Investments.
Where is Tavros Therapeutics headquartered?
Tavros Therapeutics is headquartered in Durham, United States.
What does Tavros Therapeutics do?
Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.
What stage is Tavros Therapeutics at?
Tavros Therapeutics is at the Corporate Round stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Tavros Therapeutics — Funding & Investors." VCBacked, October 12, 2022, https://www.vcbacked.co/company/tavros-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2022). Tavros Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/tavros-therapeutics
Wikipedia (cite web)
{{cite web |title=Tavros Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tavros-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K